Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
P R Health Sci J ; 31(2): 45-51, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22783695

ABSTRACT

OBJECTIVE: Triple-negative breast cancer (TNBC) demonstrates unique clinicopathological characteristics and survival outcomes. Several studies have documented important disparities in Hispanic women compared to other racial/ethnic groups; nevertheless, data on this entity in a population based Latin country are very limited. Our goal was to assess demographic and clinicopathological characteristics in essentially a pure population of Puerto Rican females with TNBC residing in Puerto Rico, as well as to determine their overall survival and progression-free survival in order to compare with published data. METHODS: By searching the electronic medical records data base, 54 patients were identified as TNBC. The median follow-up period was 25 months (range, 2-78). Univariate analysis of pretreatment risk factors was conducted. RESULTS: The median age at diagnosis was 55 years. Of 54 cases, 51 had stage I-III presentation. T1/T2 tumors were found in 88.9% and absence of nodal involvement in 68.5%. Prognostic factors for progression free survival (PFS) that were statistically significant were lymph node involvement (p = 0.02), tumor size > 2 cm (p = 0.037) and stage IV (p = 0.00002). The 5-year overall survival and PFS were 81% and 80%, respectively. CONCLUSION: RESULTS are very similar to published data on females from North America and Europe. Differences in clinical outcome and stage at diagnosis in Hispanic women with TNBC are more likely explained by socioeconomic status and adequate access to care, rather than biological/genetic differences. The association of triple-negative breast cancer with poor prognosis deserves re-evaluation given that patients with negative node involvement and no metastasis appear to be highly


Subject(s)
Breast Neoplasms , Hispanic or Latino , Adult , Aged , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Breast Neoplasms/genetics , Female , Gene Expression Regulation, Neoplastic , Genes, erbB-2/genetics , Humans , Middle Aged , Prognosis , Puerto Rico/epidemiology , Receptors, Estrogen/genetics , Receptors, Progesterone/genetics , Retrospective Studies
2.
Ann Thorac Surg ; 85(1): 334-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18154843

ABSTRACT

This is the first report describing the use of robotic technology for the treatment of chylothorax. We present a 22-year-old with mixed embryonal cell and seminoma germ cell cancer refractory to medical and surgical treatment. The patient had rising markers and a growing left lower lung lobe metastasis. After left lower lobectomy, left-sided chylothorax developed. Conservative management failed, and a robotic right-sided thoracic duct ligation was performed. Other treatment options are reviewed.


Subject(s)
Lung Neoplasms/secondary , Neoplasms, Germ Cell and Embryonal/secondary , Pneumonectomy/adverse effects , Robotics , Thoracic Duct/surgery , Adult , Chylothorax/etiology , Chylothorax/surgery , Follow-Up Studies , Humans , Ligation/instrumentation , Lung Neoplasms/surgery , Male , Neoplasms, Germ Cell and Embryonal/therapy , Orchiectomy/methods , Pneumonectomy/methods , Risk Assessment , Severity of Illness Index , Testicular Neoplasms/pathology , Testicular Neoplasms/therapy , Treatment Outcome
3.
J Surg Oncol ; 96(1): 8-13, 2007 Jul 01.
Article in English | MEDLINE | ID: mdl-17516546

ABSTRACT

BACKGROUND: Gallbladder carcinoma is a rare malignancy and is associated with dismal outcomes. The aim of this study was to better define the role of adjuvant radiation therapy in the management of gallbladder carcinoma. METHODS: The Surveillance, Epidemiological, and End Results (SEER) survey from the National Cancer Institute was queried from 1992 to 2002. Retrospective analysis was done. The end-point of the study was overall survival. RESULTS: There were a total of 3,187 cases of gallbladder carcinoma in the registry from 1992 to 2002. Of the surgical group, 35% were stage I, 36% were stage II, 6% were stage III, and 21% were stage IV. Adjuvant radiation was used in 17% of the cases. The median survival for those patients receiving adjuvant radiation therapy was 14 months compared to an 8 months median survival for those treated without adjuvant radiation therapy (P < or = 0.001). The survival benefit associated with radiation use was only presenting those patients with regional spread (P = 0.0001) and tumors infiltrating the liver (P = 0.011). CONCLUSION: The use of adjuvant radiation therapy is associated with improved survival in patients with locally advanced gallbladder cancer or gallbladder cancer with regional disease.


Subject(s)
Adenocarcinoma/mortality , Gallbladder Neoplasms/mortality , Gallbladder Neoplasms/radiotherapy , Adenocarcinoma/epidemiology , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Cholecystectomy , Cohort Studies , Female , Gallbladder Neoplasms/epidemiology , Gallbladder Neoplasms/surgery , Humans , Kaplan-Meier Estimate , Lymph Node Excision , Male , Middle Aged , Multivariate Analysis , Proportional Hazards Models , Radiotherapy, Adjuvant , Registries/statistics & numerical data , Retrospective Studies , SEER Program , Survival Analysis
4.
J Clin Oncol ; 25(9): 1043-7, 2007 Mar 20.
Article in English | MEDLINE | ID: mdl-17369567

ABSTRACT

PURPOSE: Merkel cell carcinoma (MCC) is a rare cutaneous malignancy. Because of the absence of randomized studies, the real benefit of adjuvant radiation therapy in MCC is unclear. The aim of this study was to better define the role of adjuvant radiation therapy in the management of MCC. METHODS: The Surveillance, Epidemiology, and End Results (SEER) survey from the National Cancer Institute was queried from 1973 through 2002. Retrospective analysis was performed. The end point of the study was overall survival. RESULTS: There were 1,665 cases of MCC in the SEER registry. Presentation by stage were 55% stage I, 31% stage II, and 6% stage III. Eight percent of the cases could not be staged because of incomplete data. Surgical intervention was a component of therapy in 89% of the cases (n = 1,487). The median survival for the entire cohort was 49 months, and median follow-up was 40 months. Adjuvant radiation was a component of therapy in 40% of the surgical cases. The median survival for those patients receiving adjuvant radiation therapy was 63 months compared with 45 months for those treated without adjuvant radiation. The use of radiation was associated with an improved survival for patients with all sizes of tumors, but the improvement with radiation use was particularly prominent when analyzing those patients with primary lesions larger than 2 cm. CONCLUSION: The use of adjuvant radiation therapy is associated with improved survival in patients with MCC. Prospective evaluation of adjuvant radiation therapy in this setting is warranted.


Subject(s)
Carcinoma, Merkel Cell/mortality , Carcinoma, Merkel Cell/radiotherapy , Skin Neoplasms/mortality , Skin Neoplasms/radiotherapy , Adult , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/surgery , Cohort Studies , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Staging , Radiotherapy, Adjuvant , Retrospective Studies , SEER Program , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Time Factors , Treatment Outcome , United States/epidemiology
5.
Am J Otolaryngol ; 27(1): 54-7, 2006.
Article in English | MEDLINE | ID: mdl-16360825

ABSTRACT

Parathyroid cysts rarely cause primary hyperparathyroidism. In most cases, the resultant hypercalcemia is mild and detected before any significant skeletal disease develops. We report a patient with severe hypercalcemia, a synchronous brown tumor (osteitis fibrosa cystica) of the maxilla, and a large benign functional parathyroid cyst. The unusual patient presentation and management are described and illustrated. The pertinent literature is reviewed.


Subject(s)
Cysts/pathology , Giant Cell Tumors/pathology , Hypercalcemia/diagnosis , Parathyroid Neoplasms/pathology , Biopsy, Needle , Cysts/surgery , Diagnosis, Differential , Female , Follow-Up Studies , Giant Cell Tumors/surgery , Humans , Immunohistochemistry , Middle Aged , Neoplasm Staging , Parathyroid Diseases/pathology , Parathyroid Diseases/surgery , Parathyroid Neoplasms/surgery , Parathyroidectomy/methods , Treatment Outcome
6.
Cancer J ; 11(3): 217-25, 2005.
Article in English | MEDLINE | ID: mdl-16053665

ABSTRACT

UNLABELLED: The assessment of stromal invasion in aerodigestive neoplastic squamous proliferation often poses diagnostic and therapeutic challenges. Eosinophilic infiltration is thought to be an adjunctive histologic criterion in determining tumor aggressiveness and invasion. We investigated whether an eosinophilic infiltration in head and neck squamous cell carcinoma measured in biopsies would aid in predicting tumor invasion, response to treatment, locoregional recurrence, and survival. METHODS: Eighty-seven patients with in situ and invasive squamous cell carcinoma of the head and neck region were evaluated and treated according to their staging. The number of eosinophils per high-power field (eosinophil/HPF), and per 10 high-power fields (eosinophil/10 HPF) at the tumor interface and in tumor tissue, was counted and classified as focally or diffusely present. Each sample was assigned an eosinophilic index of 1-4 based on the number of eosinophils/HPF or 10 HPF. Of 87 patients, 20 patients were followed up after appropriate treatment for locoregional recurrence, distant metastasis, and disease-free survival. RESULTS: Eosinophilic counts were elevated focally and/or diffusely more frequently in invasive squamous cell carcinoma than in noninvasive tumors. The increased eosinophilic counts, specifically > 10/HPF and > 20/10 HPF, were both significantly associated with stromal invasion. Greater than 10 eosinophils/HPF and/or > 20 eosinophils/10 HPF had the highest predictive power for invasion, with sensitivity, specificity, and positive predictive values of 66%, 94%, 96% and 61%, 100%, and 100%, respectively. Eosinophilic counts greater than 20 eosinophils/10 HPF and eosinophilic indices > 2 were virtually diagnostic for tumor invasion. Patients' biopsies with eosinophilic indices < 2 had a better survival (P = 0.0156). Using Cox regression analysis, we found that most patients' biopsies that had eosinophilic indices > 2 recurred locally or regionally. CONCLUSIONS: The elevated eosinophilic counts in biopsies and eosinophilic indices in specimens of squamous cell carcinoma of the aerodigestive tract are a histopathologic marker associated with tumor invasion and a clinical predictor for aggressive tumor biology. Similarly, the presence of eosinophils meeting these thresholds in an excisional specimen should indicate the need for additional therapeutic measures and close surveillance to detect earlier locoregional recurrence and possible distant metastasis.


Subject(s)
Carcinoma, Squamous Cell/pathology , Eosinophils , Head and Neck Neoplasms/pathology , Neoplasm Invasiveness , Neoplasm Recurrence, Local/pathology , Adult , Aged , Biopsy , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Metastasis , Predictive Value of Tests , Prognosis , Retrospective Studies , Survival
SELECTION OF CITATIONS
SEARCH DETAIL
...